Stay updated with breaking news from Wealthspan Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $5.09 on Thursday. Lipocine has a 52 week low of $3.30 […]
Keating Investment Counselors Inc. cut its stake in shares of ConocoPhillips (NYSE:COP – Free Report) by 3.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,936 shares of the energy producer’s stock after selling 350 shares during the period. Keating Investment Counselors Inc.’s holdings […]
Oakworth Capital Inc. grew its position in shares of ConocoPhillips (NYSE:COP – Free Report) by 18.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,540 shares of the energy producer’s stock after purchasing an additional 237 shares during the period. Oakworth Capital Inc.’s holdings […]
ConocoPhillips (NYSE:COP – Free Report) had its target price boosted by Mizuho from $126.00 to $127.00 in a report issued on Wednesday morning, FlyOnTheWall reports. Other analysts also recently issued research reports about the stock. Wolfe Research upgraded shares of ConocoPhillips from a peer perform rating to an outperform rating and set a $120.00 target […]
ConocoPhillips (NYSE:COP – Free Report) had its price target upped by Mizuho from $126.00 to $127.00 in a research report report published on Wednesday, FlyOnTheWall reports. Other equities research analysts have also issued research reports about the company. Barclays dropped their price target on ConocoPhillips from $160.00 to $141.00 in a research note on Thursday, […]